Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...

It's my pleasure to introduce Stephen Hoge, the President of -- Hodge? Sure. Again, thanks for us, having us here again this year. It's always a pleasure. So, yes, we reiterated that 1.5 billion ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...

Moderna's President Stephen Hoge stated, “As you know, and as I mentioned, there are additional Phase 3s as well as two randomized Phase 2s, including bladder cancer and renal cell carcinoma ...

The primary endpoint is recurrence-free survival at 12 months, with first results expected late this quarter, according to Moderna's president, Stephen Hoge. "We continue to be excited about the ...

Meanwhile, president Stephen Hoge, MD received $9.1 million last year — up from $7.3 million in 2023. Cardinal Health CEO Jason Hollar received $25.7 million in total direct compensation in 2024 — up ...

THE BUZZ: PAINT THE TOWN RED — New California GOP Chair Corrin Rankin was elected to her new post easily on Sunday and began ...